IKNA
Ikena Oncology Inc

360
Loading...
Loading...
News
all
press releases
Ikena Oncology, Inc. (NASDAQ:IKNA) Sees Large Increase in Short Interest
Ikena Oncology, Inc. (NASDAQ:IKNA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,120,000...
Ticker Report·1y ago
News Placeholder
More News
News Placeholder
HC Wainwright Reaffirms Buy Rating for Ikena Oncology (NASDAQ:IKNA)
HC Wainwright restated their buy rating on shares of Ikena Oncology (NASDAQ:IKNA Free Report) in a research report report published on Tuesday, Benzinga reports. The brokerage currently has...
Zolmax·1y ago
News Placeholder
Ikena Oncology (NASDAQ:IKNA) Earns Buy Rating from HC Wainwright
Ikena Oncology (NASDAQ:IKNA Get Free Report)s stock had its buy rating reiterated by HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They...
Ticker Report·1y ago
News Placeholder
The Analyst Landscape: 4 Takes On Ikena Oncology
Latest Ratings for IKNA DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Aug 2021Credit SuisseMaintainsOutperform Apr 2021JefferiesInitiates Coverage OnBuy View More...
Benzinga·1y ago
News Placeholder
Q1 2024 EPS Estimates for Ikena Oncology, Inc. (NASDAQ:IKNA) Lowered by Analyst
Ikena Oncology, Inc. (NASDAQ:IKNA Free Report) Investment analysts at William Blair cut their Q1 2024 EPS estimates for Ikena Oncology in a research report issued on Tuesday, March...
Ticker Report·2y ago
News Placeholder
Ikena Oncology (NASDAQ:IKNA) Given "Outperform" Rating at Wedbush
Ikena Oncology (NASDAQ:IKNA Get Free Report)s stock had its outperform rating reissued by Wedbush in a research note issued to investors on Tuesday, RTT News reports...
Zolmax·2y ago
News Placeholder
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
IK-930 continues to advance in the clinic now with an optimized formulation with improved pharmacokinetics IK-930 clinical update planned for 2H 2024 including additional data from EHE patients in...
Globe Newswire·2y ago
News Placeholder
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
BOSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena, Company ), a targeted oncology company forging new territory in patient-directed cancer treatment, today...
Globe Newswire·2y ago
News Placeholder
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
Caroline Germa, M.D., an accomplished senior executive and medical oncologist, brings over 25 years of pharmaceutical and drug development expertise Dr. Germa will drive clinical development...
Globe Newswire·2y ago
News Placeholder
Ikena Oncology (NASDAQ:IKNA) Rating Reiterated by Wedbush
Ikena Oncology (NASDAQ:IKNA Get Free Report)s stock had its outperform rating reaffirmed by equities researchers at Wedbush in a research note issued to investors on...
Zolmax·2y ago

Latest IKNA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.